Morris Arlene
- SEC CIK
- 0001362520
In the past year, 1 open-market sale filing worth $1.69M and no purchases.
Current role at each company
- COGT Cogent Biosciences, Inc.Directoras of Aug 31, 2026
- PTN Palatin Technologies IncDirectoras of Aug 5, 2026
- VRDN Viridian Therapeutics, Inc.Directoras of Jul 2, 2026
- EWTX Edgewise Therapeutics, Inc.Directoras of Jun 17, 2026
- Viveve Medical, Inc.Directoras of Jan 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.69M
- 1 filing
- Net
- −$1.69M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Morris Arlene as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
COGT Cogent Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 (view filing)5:01 PM ET | Aug 27 | 4 days | Morris ArleneDirector | SSale | −45.5K | $37.12 | −$1.69M | −100.0%0 after | 2 lots10b5-1 |
PTN Palatin Technologies Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Morris ArleneDirector | PPurchase | +33.0K | $0.62 | +$20.5K | +5.0%698.7K after | Amended |